Nosa Med AB (NOSA) — Financial Flexibility Index
Nosa Med AB (NOSA) has a Financial Flexibility Index of 0.00x as of December 2025. Free cash flow of Skr0.00 (operating CF Skr-1.78 Million minus capex Skr1.78 Million) represents 0% of total liabilities (Skr23.65 Million). Check NOSA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nosa Med AB Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Nosa Med AB across 10 annual periods. For the full cash flow conversion analysis, see NOSA cash flow metrics.
Annual Financial Flexibility Index for Nosa Med AB (2016–2025)
Year-by-year free cash flow to debt coverage for Nosa Med AB. Explore NOSA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-6.39 Million | Skr23.65 Million | ▲ +100.0% |
| 2024 | -1.31x | Skr-5.40 Million | Skr-10.03 Million | Skr4.14 Million | ▲ +50.4% |
| 2023 | -2.63x | Skr-16.64 Million | Skr-17.50 Million | Skr6.33 Million | ▼ -27.6% |
| 2022 | -2.06x | Skr-6.87 Million | Skr-6.93 Million | Skr3.33 Million | ▼ -146.0% |
| 2021 | 4.48x | Skr4.39 Million | Skr-6.21 Million | Skr980.00K | ▲ +207.8% |
| 2020 | -4.16x | Skr-60.77 Million | Skr-69.96 Million | Skr14.61 Million | ▼ -101.5% |
| 2019 | -2.06x | Skr-32.61 Million | Skr-52.72 Million | Skr15.79 Million | ▼ -50.0% |
| 2018 | -1.38x | Skr-19.56 Million | Skr-35.09 Million | Skr14.21 Million | ▲ +11.5% |
| 2017 | -1.55x | Skr-11.65 Million | Skr-27.78 Million | Skr7.49 Million | ▲ +68.4% |
| 2016 | -4.92x | Skr-17.70 Million | Skr-23.48 Million | Skr3.60 Million | — |